GeneReach Biotechnology Corp. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was TWD 283.16 million compared to TWD 186.11 million a year ago. Revenue was TWD 282.29 million compared to TWD 186.03 million a year ago. Net income was TWD 110.18 million compared to TWD 68.31 million a year ago. Basic earnings per share from continuing operations was TWD 2.4 compared to TWD 1.4835 a year ago. Diluted earnings per share from continuing operations was TWD 2.3636 compared to TWD 1.4835 a year ago.
For the nine months, sales was TWD 793.51 million compared to TWD 573.94 million a year ago. Revenue was TWD 790.42 million compared to TWD 572.25 million a year ago. Net income was TWD 312.96 million compared to TWD 166.3 million a year ago. Basic earnings per share from continuing operations was TWD 6.8091 compared to TWD 3.6205 a year ago. Diluted earnings per share from continuing operations was TWD 6.6818 compared to TWD 3.6205 a year ago.